Acute Decompensated Heart Failure

Clinical Classification


Heart failure is a widespread health concern affecting approximately 64 million people around the world; mortality is seen at a rate of 50 to 75% within five years of diagnosis.1-2  Lifetime risk has also increased, up to 24%, suggesting nearly one in four people will develop heart failure over their lifetime.3 When a patient is decompensating, it is important for the heart team to identify this early and implement a strategy to stop hemodynamic instability and hypoperfusion. 

Education Library

Acute on Chronic Heart Failure and Cardiogenic Shock

Claudius Mahr, DO, discusses outcome differences between patients with acute de novo cardiogenic shock and patients with chronic heart failure deteriorating to shock.

Predicting Mortality in Acute Decompensated Heart Failure-Related Cardiogenic Shock

A. Reshad Garan, MD, discusses the importance of determining etiology and predicting risk in patients with acute decompensated heart failure-related cardiogenic shock.

Renal Recovery in HFCS with Impella 5.5® with SmartAssist®

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5 with SmartAssist.


  1. Savarese, G., et al. (2023). Cardiovasc Res, 118(17), 3272-3287.

  2. Bragazzi, N. L., et al. (2021). European Journal of Preventive Cardiology, 28(15), 1682–1690. 

  3. Iapoce, C. (2023). HFSA: Nearly 1 in 4 US adults will develop heart failure in their lifetime. HCP Live.